Centessa Pharmaceuticals (CNTA) Equity Ratio: 2022-2025
Historic Equity Ratio for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Sep 2025 value amounting to 0.67.
- Centessa Pharmaceuticals' Equity Ratio fell 17.83% to 0.67 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.67, marking a year-over-year decrease of 17.83%. This contributed to the annual value of 0.70 for FY2024, which is 6.16% up from last year.
- According to the latest figures from Q3 2025, Centessa Pharmaceuticals' Equity Ratio is 0.67, which was down 4.02% from 0.70 recorded in Q2 2025.
- Centessa Pharmaceuticals' Equity Ratio's 5-year high stood at 0.82 during Q1 2022, with a 5-year trough of 0.66 in Q1 2024.
- Over the past 3 years, Centessa Pharmaceuticals' median Equity Ratio value was 0.70 (recorded in 2025), while the average stood at 0.71.
- Per our database at Business Quant, Centessa Pharmaceuticals' Equity Ratio rose by 19.10% in 2024 and then decreased by 17.83% in 2025.
- Quarterly analysis of 4 years shows Centessa Pharmaceuticals' Equity Ratio stood at 0.76 in 2022, then decreased by 13.33% to 0.66 in 2023, then increased by 6.16% to 0.70 in 2024, then dropped by 17.83% to 0.67 in 2025.
- Its Equity Ratio stands at 0.67 for Q3 2025, versus 0.70 for Q2 2025 and 0.73 for Q1 2025.